Table 2.
CMR findings in IVF patients
| IVF patients (n = 185) | |
|---|---|
| BSA, kg/m2 | 1.94 (±0.22) |
| LVEDV, mL | 171 (±40) |
| LVEDVi, mL/m2 | 88 (±16) |
| LVEF, % | 57 (±7) |
| Mitral valve prolapse | |
| Any MVP, n (%) | 13/182 (7%) |
| Posterior leaflet, n (%) | 7 (4%) |
| Bileaflet, n (%) | 5 (3%) |
| Prolapse, mm | 4.2 (±2.4) |
| Mitral annular disjunction | |
| Any MAD, n (%) | 112 (61%) |
| Anterolateral, n (%) | 32/182 (18%) |
| Anterolateral, mm | 3 (2, 5) |
| Anterior, n (%) | 50/174 (29%) |
| Anterior, mm | 3.8 (2, 4) |
| Inferior, n (%) | 86/180 (47%) |
| Inferior, mm | 3.6 (3, 5) |
| Inferolateral, n (%) | 24 (13%) |
| Inferolateral, mm | 3.8 (2.8, 5.8) |
| Total MAD sum, mm | 3 (0, 6) |
| Curling sign, n (%) | 11/181 (6%) |
BSA, body surface area; LVEDV, left ventricular end diastolic volume; LVEDVi, indexed left ventricular end diastolic volume; LVEF, left ventricular ejection fraction; MAD, mitral annular disjunction; MVP, mitral valve prolapse; IVF, idiopathic ventricular fibrillation.